Accelence founders

As early as 2007 the Bordeaux Chamber of Commerce and Industry offered to lead discussions with the Bordeaux University Hospital and university and hospital contacts in considering ways in which to improve scientific and economic attractiveness of the Bordeaux region with regard to clinical research.

These discussions helped to identify strengths and points which required optimization and to determine the conditions for the large industrial players to include Bordeaux in their strategies for development.

At the end of 2010, a service offer to the industry was set up in order to facilitate the performance of clinical trials: the economic interest grouping BORDEAUX CLINICAL RESEARCH NETWORK (BCRN). The Grouping is based on an alliance between public clinical research sites (the university and hospitals) and industrial partners:

Well supported by the high level of involvement of its founding members (2,000 physicians, 5 major hospital sites, over 200,000 patients per year), ACCELENCE offers a significant capacity for the performance of clinical trials over a wide range of therapeutic areas, additionally including specific fields of expertise: neurology, oncology, cardiology, metabolic syndrome, infectious diseases, pediatrics, geriatrics…

On September 9th 2011, BORDEAUX CLINICAL RESEARCH NETWORK became ACCELENCE.

THE BORDEAUX UNIVERSITY HOSPITAL

  • Managing Director: Mr. Philippe Vigouroux

Number one employer of the Aquitaine region, Bordeaux University Hospital is composed of 3 hospital complexes, 13,500 employees -including over 2,000 physicians and almost 200 research professionals- and over 3,000 beds.

The Bordeaux University Hospital, clinical research operator and sponsor of biotechnological innovation:

A desire to develop clinical research and innovation, based on a translational approach, in close collaboration with Bordeaux University and research organizations (13 teams approved by Inserm, 13 by the National Center for Scientific Research (CNRS) and 2 by the National Institute for Agricultural Research (INRA));

A high level of commitment to the national program « Investments of the Future », namely including a Hospital and University Institute for rhythmology and cardiac modeling (IHU LIRYC), Excellent Equipment (EquipEx) and the association of two Laboratories for Excellence (LabEx).

A policy for clinical research based on:

  • 2 themes relating to organ diseases:

– Pathology of the nervous system

– Cardiothoracic pathology

  • 2 themes relating to major pathogenic processes:

– Oncology

– Infectiology

  • 2 themes with a technological focus:

– Medical imaging

– Biomaterials and functional substitution

  • Structuring of emerging themes concerning which the Bordeaux University Hospital has a high level of experience (nutrition, nephrology, immunology and organ transplants) or themes such as rare diseases for which the Bordeaux University Hospital has a significant number of approved reference Centers nationwide.

Key opinion leaders known nationally and internationally in a large number of disease areas.

A Clinical Investigation Center (CIC) approved by the Ministry of Health and by Inserm, with:

  • A Multithematic module based around neuroscience, oncology, respiratory medicine, pharmacoepidemiology and cardiology;
  • A Clinical epidemiology module based around aging, oncology, chronic diseases and general practice, methodological innovation;
  • A Technological innovation and biomaterials module based around bone and vascular repair.

A unit for methodological support to clinical research and epidemiology, a platform for technological biomedical innovation and 10 rare disease centers.

200 clinical trials sponsored by the Bordeaux University Hospital and a thousand by other sponsors (of which over 400 are industry-sponsored).

THE INSTITUT BERGONIÉ

  • Managing Director: Pr. François-Xavier MAHON

The Institut Bergonié was founded in 1923 by Professor Jean-Alban Bergonié. It was the first Comprehensive Cancer Center (CLCC) to be founded outside of the Paris area. On April 11th 2011, the 20 CLCCs from all over France grouped together as the UNICANCER group. The symbolism of this name is important – to unite people and resources and to ensure unity of action in the fight against cancer.

With over 49,000 consultations, around 18,000 patients and almost 8,000 hospitalizations per year, the Institut Bergonié has a triple mission of care, research and teaching for the 3.3 million people living in the Aquitaine region and in five neighboring areas.

As a reference establishment, it guarantees adapted diagnostic and therapeutic strategies, as well as access to constantly progressing knowledge in oncology, for the whole population of South-West France. The Institut Bergonié incorporates two INSERM units and has developed an advanced technical platform (imaging, nuclear medicine, biology, pathology). It has a dynamic renewal and innovation policy in the field of biomedical equipment, and is extending its research laboratory potential with, for instance, the recent construction of a biosafety P3 laboratory.

The Institut has also decided to offer training services externally and has set up the “ATRIVM” structure which is dedicated to organizing training courses.

Every year the Institut Bergonié implements new research projects and today it is one of the highest-ranked centers in the field of clinical trials.

Some key figures:

  • 86,544,989 € annual turnover
  • 852 employees, including 107 physicians
  • 190 beds
  • 17,776 patients for 49,110 consultations/year
  • 7,929 hospitalizations

Key opinion leaders in numerous fields of expertise: breast cancers, sarcomas (accredited national reference center), digestive cancers, gynecological cancers (accredited center for rare ovarian tumors), urologic cancers, hematological cancers, lung cancers and some thyroid cancers, accredited center for early phase clinical trials.

THE UNIVERSITY OF BORDEAUX

Biology-health, the expertise of the University of Bordeaux  

  • President : Pr. Manuel Tunon de Lara

The University was founded on January the 1st, following the merger of the Universities of Bordeaux, Bordeaux Segalen and Bordeaux IV. Bordeaux Segalen had participated in the creation of ACCELENCE on November 25th, 2014″

Life and health in all its aspects (medical, biological, societal and collective) are the sciences around which the Bordeaux Segalen University is built, with Man in the very heart of the project.

Of the 19,400 students trained each year at the Bordeaux Segalen University, 65% follow a « biology / health » curriculum. This covers all training in the areas of medicine, odontology, maieutics, pharmacy, applied biology and public health, and combines theoretical training with clinical practice at the Bordeaux University Hospital. Note: the number of students at Bordeaux Segalen University makes it one of the largest French faculties of medicine. Namely due to the high level of training given in the fields of public health, thermatology, the pharmaceutical industry and health, the University offers strong potential for the recruitment of highly-trained staff for research and clinical trials.

The only one of its kind in the Aquitaine region, the « biology-health » center is organized around research areas of international renown: neuroscience, public health – society, fundamental biology and biology applied to medicine and to technology for health. This research is based on close collaboration with national organizations (INSERM, CNRS, INRA, INRIA) and on technological shared platforms and units, setting Bordeaux up as one of the largest French sites for biomedical research. Indeed the Bordeaux University (of which Bordeaux Segalen has been an active member from the start) was awarded the national call for projects « Initiative for excellence » in July 2011 and obtained significant financing for the setup, among other things, of a Hospital/University Institute dedicated to electrical cardiac diseases, of two laboratories for excellence in the fields of inter- and multidisciplinary research in bio-imaging and neuroscience, of an infrastructure for cellular photonic and electronic bio-imaging, for a cohort of students.

Department of Life and Health Sciences in figures:

  • 600 years of university tradition
  • 1,000 research professors of which 600 work both for hospitals and for the university
  • 6 federative research pools and 50 research laboratories attached to Inserm, the CNRS or INRA
  • 19,400 students of which 2,100 are foreign students
  • 191 national diplomas and 331 university diplomas
  • 430 PhD students and 105 dissertations defended each year
  • 161 M€ annual budget

1st public/private R&D accelerator in Europe
1st public/private R&D accelerator in Europe
You have a project? A question? Contact us
Clinical research capabilities for the Bordeaux region
Clinical research capabilities for the Bordeaux region